If the company keeps on failing to impress, it can go below 10c. But I have a gut feeling that it may be able to the corner for FY17.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential